Bioimpedance Spectroscopy Compared to CardioMEMS™

NCT02857231 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 16

Last updated 2019-07-08

No results posted yet for this study

Summary

Comparison of changes in diastolic pulmonary artery pressure as measured by CardioMEMS™ to impedance parameters as measured by ImpediMed's BIS technology.

Conditions

  • NYHA Class III Heart Failure

Sponsors & Collaborators

  • ImpediMed Limited

    lead INDUSTRY

Principal Investigators

  • James T Heywood, MD · Scripps Clinic

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-07
Primary Completion
2018-03-19
Completion
2018-10-09

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02857231 on ClinicalTrials.gov